医学
氧化应激
神经炎症
缺血性中风
冲程(发动机)
缺血
内科学
丙二醛
心脏病学
药理学
精神压力
缺血性损伤
麻醉
疾病
脑缺血
压力(语言学)
作者
Bingyuan Liu,X P Chen,Luyun Tu,Lixin Yin,Hongxia Huang,Y Wu,Hui Cai,Yiliang Li,Sheng Hong
标识
DOI:10.1016/j.mtbio.2026.103392
摘要
Ischemia-reperfusion injury (IRI) following thrombolytic therapy significantly influences the ischemic stroke outcomes. Here, we develop M@EFE NPs, a biomimetic nanomedicine, to alleviate the reperfusion injury. This nanomedicine is constructed by encapsulating Edaravone into the metal-phenolic nanoparticles self-assembled from epigallocatechin gallate (EGCG) and iron ions (Fe 3+ ), and further coating with macrophage membranes. This design integrates the antioxidant and anti-lipid peroxidation properties of the EGCG-Fe 3+ nanoparticles with the inflammatory targeting capacity of macrophage membranes. Following systemic administration, M@EFE NPs are able to penetrate the blood-brain barrier and target the ischemic regions, thereby inhibiting oxidative damage, protecting neurons, and ultimately improving stroke outcomes. In vitro , the nanomedicine can effectively scavenge reactive oxygen species, inhibit lipid peroxidation, and enhance cell survival. In murine middle cerebral artery occlusion models, M@EFE NPs could reduce infarct volume, attenuate neuronal apoptosis and neuroinflammation, and improve motor recovery and long-term survival. This study presents a promising combinatorial nanotherapeutic strategy for ischemic stroke, providing insights into biomimetic nanomedicine for treating cerebral IRI.
科研通智能强力驱动
Strongly Powered by AbleSci AI